LiveJournal is a blogging platform where users can publish and comment on blogs, follow others, and participate in collective blogs.

LiveJournal combined blogging and social networking, setting it apart from other platforms.

The platform's history began when Brad Fitzpatrick transformed his personal journaling application into a public website.

LiveJournal had over 2.5 million active accounts at its peak in early 2005.

LiveJournal ratings increase with engagement and decrease with less, though the exact principle is secretive.

The rise of platforms like Facebook contributed to the decline of earlier sites like Myspace and LiveJournal.

Failing to adapt to changing trends contributed to the decline of social media platforms, including LiveJournal.

Intense competition and emerging alternatives likely contributed to LiveJournal's decline.

LiveJournal was blocked in Kazakhstan from August 20, 2011, due to terrorism and extremism propaganda.

The block was lifted on November 11, after LiveJournal removed the illegal materials, restoring access for users in Kazakhstan.

New social media platforms have led to a decline in older ones like LiveJournal as users switch to newer alternatives.

The decline of social media platforms is due to their failure to adapt to trends, privacy concerns, competition, and new alternatives.

The rise of Facebook, Twitter, Instagram, and Snapchat contributed to the decline of older platforms like MySpace, Orkut, Vine, and possibly LiveJournal.

LiveJournal is a blogging platform where users can publish and comment on blogs, follow others, and participate in collective blogs.

Title:

Content: LiveJournal is back in Kazakhstan
519
Anna VLADIMIROVA
Access to the "Live Journal" was restored after the administration of the LiveJournal blog platform executed the decisions of the judicial authorities of Kazakhstan on the removal of illegal materials posted on the resource.
Representatives of LiveJournal reported on the removal from the blogging platform of materials containing signs of propaganda of terrorism and religious extremism, public calls to commit acts of terrorism and the manufacture of explosive devices.
Earlier, the Saryarka court of Astana issued a decision to close access to the “Live Journal ” from August 20, 2011 due to the distribution of these materials.
As a result, the Committee of Communications, Informatization and Information of the Ministry of Investment and Development of the Republic of Kazakhstan decided to resume access to the resource on the territory of Kazakhstan from November 11 this year.
LiveJournal also plans to open a representative office in Kazakhstan and develop the Kazakhstan segment of the blogging platform.
For reference: “Live Journal ” is a blogging platform for keeping online diaries (blogs).
Provides the ability to publish your own and comment on other people ’ s records, conduct collective blogs (“communities ”), add other users to friends and follow their records in the“ friends feed ”.
Popular
All
More than 2,000 killed in Morocco earthquake
Kazakhstan - Northern Ireland: live broadcast of the match can be viewed at EXPO
Unfavorable weather conditions are expected in two cities of Kazakhstan
Kassym-Jomart Tokayev congratulated Kazakhstanis on Family Day
Morocco declares three days of mourning for earthquake victims
Kazakhstan chess players made their way to the semifinals of the World Cup 2023
A powerful causative agent of tumor growth was vitamin C
The Ministry of Emergency Situations told the details of the fire in the bath complex in Almaty
In the south-east of Turkey fell meteorite
Cristiano Ronaldo's New World Record
Kazakhstan became the champion of tennis tournament in Prague
Shootout in a cafe in Almaty: the state of the victims told in the city health
Two visitors of the cafe were injured in a shootout in Almaty
Three people were burned in a fire in Astana
It was a drought, and now it rains.
A benevolent atom
A number of tasks were set for the new akim of Aktobe region
The archive that filmmakers have been waiting for
Heavy rains flooded Las Vegas
Tokayev appointed the head of the new Ministry of Industry and Construction
Shandong is the third trade regional partner of Kazakhstan in China
Creativity is now at a price.
Impostor Trash
Tens of thousands of people are stuck at the festival in the United States because of the rains
Typhoon Haikui is approaching Taiwan
Businessmen want to pay for water as pensioners
Fair within Days of Culture of Tajikistan in Kazakhstan to be held in Astana
Minister of Education of the Republic of Kazakhstan spoke about wearing the hijab in schools
Kazakhstanis will be able to transfer license plates to the new owner online
Muza Kayuma Mukhamedkhanova
"Golden mine" in the vicinity of Maralda
How to learn a language and make friends
Presidents Tokayev and Rahmon visited the Main Mosque of Astana
Dinmukhamed Kunaev: I believe in my people, their future is bright
Where to watch live the fight Kosobutsky - Adjagba
A foreigner who was on the run for 15 years was detained in Astana
The fire at the mine "Kazakhstan": what kind of help will the affected miners receive
Rescuers found a tourist missing in the mountains of Kok-Zhailau
Behind the wheel of a service car and without a license removed a relative of a police chief in Shymkent
Residents of Semey demand to cancel the entrance fee to the cemetery
Tajik citizens arrested in Almaty for robbery
In Semey, the memory of the victims of nuclear tests was honored
Dead girl found mushroom pickers in Kostanay region
Double murder in Arys: detained the alleged customer and executors
5-year-old niece beaten by girl in Astana – reaction of police and children ’ s ombudsman
A military driver saved a teenage girl from suicide in Astana
Read also
Pricing in life
I swear I will burn my tongue!
Another palace.
Icebreaker
Do not deprive the living space
Archive
• [[year]]
• [[month.label]]
• [[day]]

After Russian users could no longer use foreign social networks, where did they post their blogs?

LiveJournal combined blogging and social networking, setting it apart from other platforms.

Title:

Content: Regulators Seem to Think That Facebook Is the Internet

That’s a problem.

In 1997, SixDegrees.com was the first real attempt at social networking, creating a space where users could upload their information and list their friends. The site peaked at approximately 3.5 million users before it shut down in 1999.

Since then, a series of social networking business models have emerged, each time offering more advanced tools for user interaction. LiveJournal, a site for keeping up with school friends, combined blogging and social networking features inspired by the WELL; Friendster was a social network that allowed for increased interaction and control by users; Myspace had open membership and gave users the freedom to customize their pages. In 2005, it—and its 25 million user base—was sold to News Corp. But within three years, Myspace had been surpassed by Facebook, which launched in 2004 for college students and opened to everyone in 2006.

Advertisement
Advertisement
Advertisement

As that history shows, in the early days of the internet, disruption was profound and constant: New companies emerged in music, video, e-commerce, publishing, and telephony on an almost yearly basis. The internet appeared to be a space where competition could thrive.

Not anymore.

Today, disruption happens in much smaller ways. The examples are getting fewer because economies of scale have concentrated innovation in the hands of a few players.

More often, disruption comes from regulation—for better or, often, for worse. Current regulation attempts focus on the actions and behavior of some actors—chiefly Facebook—while creating unintended consequences for the internet, particularly fragmentation, or the splintering of the global internet into one that more closely hews territorial borders.

Advertisement

It’s understandable that both the public and regulators might think that regulating “the internet” means focusing on the biggest players. Much of it has to do with the fact that users are often exposed to various types of illegal behavior and content through some of the most popular services that exist on the internet. Fix misinformation, or extremism, or ideological silos, or security on Facebook, the thinking goes, and you’ve fixed it on the internet as a whole.

Advertisement

But this is an unhelpful and misguided narrative. First, the internet is not a monolith, so treating it as if it is simply will not work. Second, many of the issues regulators are trying to address are not internet problems; they are societal. Terrorism, child abuse, and mis- and disinformation are not an offspring of the internet; they existed before the internet, and they will continue to exist after it as they are ingrained in human societies. Yet, they are treated as if they are exclusively internet problems. Third, and most importantly, regulators should stop thinking of the internet as Facebook and treating it as such. In the internet regulatory landscape, there is a mixed bag of different issues, and Facebook’s involvement in all of them, direct or indirect, adds to the current complexity. Content moderation, privacy, intermediary liability, competition, encryption—these are all broader issues related to the internet, not just Facebook. Yet, the pattern that has emerged is to treat them as Facebook issues. What this means is that, instead of focusing on trying to address them in ways appropriate for the entire internet ecosystem, they are addressed through the Facebook lens. This has been quite accurately characterized as the “Facebook Derangement Syndrome.”

Advertisement
Advertisement

The global regulatory agenda is replete with such examples. In the United Kingdom, the Online Safety legislation wants to ban end-to-end encryption because of Facebook’s plan to introduce it as a default setting in its Messenger service. On the other side of the Commonwealth, Australia recently introduced a media bargaining code mainly targeting Facebook. Facebook famously “left” the country before renegotiating a new agreement. Similarly, in what seems to be a coordinated effort, Canada has vowed to work with Australia in an attempt to impose regulatory restrictions on Facebook.

And this trend is not limited to the Commonwealth.

India’s new intermediary guidelines aim at tightening a regulatory grip on Facebook and its partner company WhatsApp while Brazil’s fake news bill, which got approved by the Senate, is focusing on content moderation on Facebook and traceability on WhatsApp. In France, there have been conversations about the introduction of “new rules” for Facebook, while Germany’s Network Enforcement Law—NetzDG—was drafted with the primary focus of taming Facebook. Finally, in the United States, the Trump administration issued an unsuccessful executive order that aimed to regulate Facebook for bias.

Advertisement

This approach of limiting regulation to Facebook is not entirely unusual. It reflects the principal-agent conundrum that, over the years, has allowed companies like Facebook to  propose policies and deploy tools that can have an impact on the way regulation gets to be enforced. The principal-agent problem is predominantly characterized by conflict of interest and moral hazards. Due to information asymmetries, the agent holds the bargaining power, and this creates a few unknowns: The principal is in no position to know the information the agent holds. Even when she does, she cannot be certain that the agent is acting to her best interest. So, the principal ends up focusing squarely on the agent, disregarding any peripheral issues that might be significant.

Advertisement
Advertisement

The principal-agent problem may help explain why governments appear ready to introduce regulation targeting Facebook; however, it does not help explain why, in the process of doing so, the main loser is the internet and its users.

Over the past couple of years, Facebook has said, “We support regulation,” and “we want updated internet regulations to set clear guidelines for addressing today’s toughest challenges.” This statement would be significant if it did not come across as self-serving. At this stage, regulation is inescapable and Facebook knows it—as does the rest of big tech. In an effort to adapt to this new reality, companies often take advantage of their dominant position to drive regulatory processes, often at the expense of regulation itself.

Advertisement

In this context, the question we should be asking is not whether regulation is appropriate, but what are the real implications of regulating in such a manner? There is already an argument that focusing on a few, big players has an impact on the health of innovation and the ability of newcomers to compete. And, then, there is the internet. The internet’s global reach is one of its main strengths. It is a feature, not a bug. Among other things, it allows the maintenance of supply chains all over the world; it allows people to communicate; it lowers costs; and it makes information sharing easier, all the while helping to address societal issues like poverty or climate change.

Advertisement
Advertisement

To this end, the attempt to regulate based on one—or a handful—of companies can jeopardize this very important goal of the internet. It can create fragmentation, in the sense of not allowing data to flow across borders or networks to interconnect, and this can be very real and have a very big impact. It can impose limits on the way information and data gets to be shared and the way networks may interoperate. These are significant trade-offs, and they must be part of any regulation’s process.

Advertisement

So where do we go from here?

For sure, the answer cannot be to stop regulating. We must accept, however, that the current approach often generates unintended consequences that only superficially affect those who must be regulated.

In this light, a possible way forward is to experiment with regulation. Experimental regulation is a relatively underused approach, yet it is flexible enough to accommodate dynamic markets, like the internet. Originally associated with the work of John Dewey, this idea is premised on the fact that, in policymaking, the way we approach theories and strategies of justice depends on “the experience of their pursuit; it is these changes that then allow us to consider how best to achieve our objectives.” The advantage of this thinking is that it considers unintended consequences as an opportunity to better define appropriate regulatory frameworks and how to achieve the desired goals.

Advertisement

Internet regulation does not experiment enough, and when it does, it appears to have the wrong focus. In Australia, for instance, the effort to ensure robust journalism in an age of disinformation in social media platforms led to a “link tax” that undermines the architecture, history, and economics of the internet. This is partly due to the role big tech companies play in the regulatory process. One of the immediate things one can observe with internet regulation is the process some actors deploy: In the beginning, they operate in favor of sustaining existing policies and bureaucracies. The thinking is that longevity brings legitimacy, and as a result, the policy becomes its own cause. Once this strategy is embedded in process, these powerful forces move toward pushing their own regulatory agenda.

Advertisement

It is for this reason that there is a certain appeal toward flexible regulatory systems that allow different units to experiment with different approaches and make room for assessments that separate the relevant from the nonrelevant and preexisting rules. Although experimentation neither offers a drastic approach nor aims to replace traditional routes of regulation, it can limit the risks of politicization, as politics become more context focused.

One of the first things we need is an internet impact assessment that looks at the different parts of the internet’s infrastructure and the effect that regulation may have. It is no longer just about regulating a few actors. It is about protecting the global infrastructure that we all depend on daily.

The internet has a Facebook problem, but the internet is not Facebook.

This article represents the views of the author and not those of his employer, the Internet Society. Facebook is an organization member of the Internet Society.

Future Tense is a partnership of Slate, New America, and Arizona State University that examines emerging technologies, public policy, and society.

Advertisement

The platform's history began when Brad Fitzpatrick transformed his personal journaling application into a public website.

LiveJournal had over 2.5 million active accounts at its peak in early 2005.

LiveJournal ratings increase with engagement and decrease with less, though the exact principle is secretive.

Title:

Content: Opinion: Rating in Russian
27.05.2022, 22: 21, Miscellaneous
Subscribe to Telegram channel
Subscribe to Google News
Starting from February 24, interesting metamorphoses occur with my LJ rating (trifle, but unpleasant).
LiveJournal, apparently, defined me as an “unreliable ” user – and therefore he is just monotonically declining.
Of course, the principle of forming LiveJournal ratings has always remained a terrible military and commercial secret, but the general principle could be caught: if you are read a lot, your posts have a lot of comments and likes, the rating increases; if you read a little, there are no comments, or you do not write anything at all, the rating decreases.
It's kind of simple.
But with the beginning of the war, LiveJournal not only introduced censorship and canceled anonymous names, but also, it seems, revised the principle of rating.
Now the “unreliable ” users ratings simply decline no matter what.
I noticed it back in April – when on one of the posts (about AvtoVAZ) there was almost a record attendance – 75 thousand per day, about 1000 comments – and the rating, as if nothing had happened, continued to decline.
I am almost certain that the LJ algorithm has a restriction, according to which it by default believes that “Shoemaker writes nothing ”; accordingly, every day my personal rating gradually dries up, although I still have, even in conditions of censorship and general militaristic insanity, extremely“ fruitful ” posts.
All this is understandable – LJ, while he was “in the shadows ” and outside the attention of the“ ideologists ” of the regime, lovingly debugged his mechanisms of work and brought them almost to perfection, but when censors and censorship came, it breaks everything down in a few months, since the mechanisms were made with an emphasis on the objectivity of measurements, and no objectivity of ideology is needed.
I just don ’ t understand why it ’ s so half-hearted.
With other "unreliable" treated much cooler.
Kungurov was simply squeezed out of LiveJournal, Nikonov was squeezed out, Mitrich ’ s rating was simply halved in one fell swoop, Alex Rozoff was driven somewhere in the end of the first rating hundred (although his posts are read and discussed in the same way, if not more than before the sad Free Date) – and my rating is just slowly and sadly “blown away ” (about minus 8 thousand points), and almost ceased to include posts in the Top.
The only thing is that I ’ m treated about the same as El Murid: he ’ s also “slowly and sadly ” losing in the rankings, although his posts are read almost more than mine (but since we have the same rate of fall in the“ they write nothing ” mode, I can ’ t fall lower than him).
These are the ratings quirks.
Source: Reflections of a Free Sociologist
View commentsNo comments
Privacy Policy - GDPR
Site map →
For information cooperation, advertising and publication of ads, write to the address: [email protected]
Support the project:
UMoney- 410011013132383
WebMoney – Z399334682366, E296477880853, X100503068090
18 + © 2002-2021 RYBINSKonLine: All you wanted to know...

How is a writer on LiveJournal ostensibly rated reliable?

The rise of platforms like Facebook contributed to the decline of earlier sites like Myspace and LiveJournal.

Failing to adapt to changing trends contributed to the decline of social media platforms, including LiveJournal.

Intense competition and emerging alternatives likely contributed to LiveJournal's decline.

Title:

Content: 23 / 06 / 2023 - 13: 25
The rise and fall of social networking sites: major projects that have faded over the past years
In recent years, the Internet has seen the rapid rise and subsequent disappearance of social media platforms, which according to studies can be attributed to the failure to adapt to changing trends, privacy concerns, intense competition, and the emergence of more alternatives.
(Getty)
The rapid development of the digital age has brought many changes to the ways of communication over the past years, as the Internet world has witnessed the rise and fall of various communication sites, platforms that once flourished and flourished but eventually faded into oblivion.
In recent years, the Internet has seen the rapid rise and subsequent disappearance of social media platforms, which according to studies can be attributed to the failure to adapt to changing trends, privacy concerns, intense competition, and the emergence of more alternatives, which also indicate the rapid pace of technological progress and the need for continuous innovation.
MySpace has enjoyed unprecedented popularity during the mid-2000s, providing users with a platform to connect, share media and express themselves creatively, however, the decline of MySpace began when Facebook emerged as a dominant force in the social media landscape, studies show that MySpace failed to adapt to the changing preferences of their user base. This resulted in a loss of relevance and decreased user engagement.
Launched in 2004, Orkut was a pioneer in social networking, particularly in countries such as Brazil and India, and despite its early success, Orkut struggled to combat spam, privacy concerns and the rise of rival platforms such as Facebook and Twitter.
As studies indicate, the lack of innovation and failure to address these issues eventually led to their demise in 2014, which also happened with the site "First Messenger" which was once an integral part of the lives of many people on the Internet, allowing users to communicate in real time and facilitate conversations and enhance communication between users. Like WhatsApp and Facebook Messenger, they have wiped out the site ’ s last hope of survival, amidst this massive and rapid technological development.
In 2011, Google Plus was launched, which was aimed at competing with Facebook and creating a social network within Google ’ s ecosystem, and despite the company ’ s vast resources, it failed to attract a large user base, which led to the fall of the application in 2019, which led to the company ’ s closure of the project due to a decline in the number of users.
In another example, Vine had gained immense popularity with its unique six-second videos, which served as a breeding ground for budding creators and led to numerous viral trends, however, Vine ’ s downfall is attributed to its failure to monetize content effectively, and the emergence of rival and powerful platforms such as Instagram and Snapchat.
Delicious is a harsh example of the fall of a social media platform, where the site faced major challenges due to the lack of effective monetization strategies, and the emergence of new competitors on the platform, which led to a sharp decline in the user base, and ultimately sold and re-launched, under new ownership.

LiveJournal was blocked in Kazakhstan from August 20, 2011, due to terrorism and extremism propaganda.

The block was lifted on November 11, after LiveJournal removed the illegal materials, restoring access for users in Kazakhstan.

New social media platforms have led to a decline in older ones like LiveJournal as users switch to newer alternatives.

The decline of social media platforms is due to their failure to adapt to trends, privacy concerns, competition, and new alternatives.

The rise of Facebook, Twitter, Instagram, and Snapchat contributed to the decline of older platforms like MySpace, Orkut, Vine, and possibly LiveJournal.


The number of drug shortages in the US has reached a record high of 323 drugs in the first three months of 2024, according to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service.

All drug classes are vulnerable to shortages, with some of the most worrisome shortages including sterile injectable generic drugs, cancer chemotherapy drugs, and emergency drugs.

The economic implications of drug shortages on healthcare systems include the costs of workforce diversion, extended hospital stays, and other resource reallocations.

Manufacturing and quality problems, such as supply chain gaps and downtime, are often the root cause of drug shortages, rather than just high demand.

The FDA has identified manufacturing and quality problems, supply chain gaps, and downtime as contributing factors to drug shortages.

The shortage of generic chemical drugs can be caused by the closure of a single factory that manufactures the active ingredient, highlighting the need for greater transparency and diversification in the pharmaceutical supply chain.

Technology, specifically artificial intelligence, can be used to predict the structure of proteins, which may speed the discovery of new drugs.

Data on drug availability, such as that provided by the Food and Drug Administration, can help track and respond to drug shortages.

The use of technology, such as the 'Drug Supply Information Platform', can help predict, prevent, and respond to drug shortages by providing real-time information on drug availability and alternative drugs.

Data analytics can be used to identify patterns and trends in drug shortages, allowing for proactive monitoring and early intervention.

Digital health solutions, such as the 'Universal Health Insurance Cost Distribution Target System', can help adjust drug prices and quotas, taking into account various factors that affect drug supply and demand.

The Ministry of Health and Welfare has proposed a short, medium, and long-term strategy to deal with the current drug shortage.

The shortage of drugs is caused by multiple factors, including supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits, and drug prices.

The COVID-19 pandemic has accelerated the adoption of new technology, with companies digitizing activities 20-25 times faster than previously observed, according to a McKinsey study.

Data analytics and digital health solutions can play a crucial role in predicting, preventing, and responding to drug shortages by providing real-time monitoring and insights.

The Taiwanese government has launched a 'Drug Market Monitoring System' to strengthen the monitoring of pharmaceutical product supply in the middle market.

The 'Drug Market Monitoring System' allows front-line pharmacists to query the inventory of pharmaceutical products more quickly, ensuring the rights and interests of the public.

India's healthtech sector is growing due to the increasing adoption of digital health solutions.

Digital health solutions, such as telemedicine platforms, are improving healthcare outcomes by reducing barriers to access and enabling remote consultations.

The Health Committee of the Shura Council discussed the importance of benefiting from programs, large databases, and artificial intelligence to predict demand for ambulatory services.

Artificial intelligence can help guide supervisors of ambulatory services to transfer or focus crews to fill excess requests and raise efficiency.

Drug shortages are estimated to cost facilities at least $359 million per year.

More than 50,000 institutional and retail pharmacies across North America are affected by drug shortages.

Technology and automation can play a role in predicting, preventing, and responding to drug shortages, as evidenced by Omnicell's advancements in automation, intelligence, and technology.

The use of data analytics and digital health solutions can potentially help mitigate the effects of drug shortages.

The main challenges in implementing technology, data analytics, and digital health solutions to address drug shortages include unsupportive regulatory systems and limited human capacity.

Local production of medicines plays a vital role in maintaining the resilience of national healthcare systems by facilitating access to needed medicines and reducing reliance on international supply chains.

Digital health integration and AI are considered vital solutions to enhance patient care and address biases in the healthcare system.

The adoption of artificial intelligence (AI) can deliver personalized care more efficiently, and hospitals have started using predictive modeling capabilities to prioritize cases.

The accuracy and integrity of healthcare data, particularly in electronic medical records (EMRs) and data structures, are essential for informed decision-making.

The Digital Health Market is expected to reach $586.59 billion by 2030, growing at a CAGR of 16.80% during the forecast period (2023-2030).

The main challenges facing the Digital Health landscape include interoperability issues, data security concerns, and the need for standardized regulations.

Achieving seamless integration across diverse platforms, ensuring patient privacy, and addressing resistance to technology adoption are pivotal challenges in the Digital Health Market.

Digital health tools can address issues of lack of healthcare access, lack of coordinated care, and interoperability problems in a streamlined and personalized way.

Digital health has successfully integrated technology into healthcare by facilitating on-demand, whole-person monitoring.

The biotech and pharma spaces are often lagging in adopting new technology due to regulatory and validation requirements.

Proper use, interpretation, and understanding of data are required for efficiency and successful outcomes in the biopharma world.

The growth of e-mental health care has been huge, with a 6,500% increase in doctors recommending apps to patients in 2021.

E-mental health solutions depend on people having access to technology platforms and data plans, which can exclude those who need mental health support the most, such as older people, people with low incomes, and those with severe mental health problems.

Complex regulatory issues, such as ensuring apps meet quality standards, are a challenge for large-scale implementation of e-mental health options.

The research and development costs for digital health are high, which can divert funding away from person-to-person care.

The Saudi Food and Drug Authority faces challenges in raising the efficiency of services provided and creating innovative technical solutions to enhance the quality of services and stimulate digital infrastructure.

The Authority's website contains indicators and an interactive panel with information on the shortage of medicines, raw materials, and devices, which is updated regularly.

The use of artificial intelligence has the potential to help predict the increase or decrease of demand for ambulatory services and guide supervisors to transfer or focus crews to fill excess requests.

The use of large databases and artificial intelligence can help raise the efficiency and better use of resources in ambulatory services.

The number of drug shortages in the US has reached a record high of 323 drugs in the first three months of 2024, according to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
An Unexpected Catastrophe in the World ’ s Largest Country: The Complete Story of U.S. Drug Shortages
The deficit is at a record level.
According to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service, organizations began tracking drug shortages for the first time in 2001. Steady since 2021 – now reaching a record high of 323 drugs in the first three months of 2024.
Paul Abramowitz, CEO of the American Society of Health System Pharmacists, wrote in a blog post on Thursday: “It ’ s been a long time to end drug shortages, ” and wrote:“ All drug classes are vulnerable to shortages, some of the most worrisome shortages include sterile injectable generic drugs, including cancer chemotherapy drugs and emergency drugs stored in hospital vans and procedural areas. It is dangerous for doctors and patients. ”
In addition to the 32 chemotherapy drugs that are deficient, the five categories of drugs with the greatest deficiency include central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids. [1] The Drug Deficiency Database maintained by the American Society of Health System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients, and others that have been confirmed by manufacturers. The U.S. drug is in short supply, because it captures broader effects on service providers and patients.
The crisis has lasted a year and a half.
More than half of the treatment shortages have lasted for more than two years, according to an analysis by health consultancy IQVIA, and the average shortage affects at least half a million patients, many of them elderly, according to the US Office of Health and Human Services under the Assistant Secretary for Planning and Evaluation, which shared its analysis with Congress in May.
Growing demand can play a role in drug shortages, as with the recent shortage of weight-loss drugs, but often manufacturing and quality problems, such as supply chain gaps and downtime, are the root cause. And varied.
But the American Society of Health System Pharmacists has “serious concerns ” about parts of this proposal, especially financial sanctions imposed on hospitals that lack the resources to comply with the recommendations, Abramowitz wrote:“ We all know that managing shortages is not enough and is not a sustainable solution to the worsening crisis, and there is still a lot of work to be done at the federal level to fix the root causes of drug shortages. ”
Why Shortage Occurs
Shortages can be caused by high demand, as with the recent shortage of weight-loss drugs, but this is not usually the main problem.
The FDA also blames manufacturing and quality problems, supply chain gaps, and downtime, and Dr. Emily Tucker, a drug shortage expert and an assistant professor of industrial engineering at Clemson University, says that when there is an indication of shortages, large health systems often also proactively place large orders, adding to the system ’ s stress.
“I don ’ t blame anyone.
“When I talk to all the stakeholders – whether it ’ s wholesalers, manufacturers, or the government – everyone wants this problem to end, ” she said.
Lack of transparency
Dr. Julie Grallo, chief medical officer and executive vice president of the American Society of Clinical Oncology, told the House Committee earlier that the shortage puts providers in a terrible position: “The drug shortage crisis is forcing providers to make impossible choices, and it is also hindering the development of new drugs. Health drugs are purchased only on a price basis, and manufacturers do not have to disclose the source of their acquisition of the ingredients.
The shortage of this generic chemical drug came due to the closure of one factory in India that manufactures the active ingredient after a surprise FDA inspection found “significant quality issues, ” says Jarallo:“ We didn ’ t know, and there was no transparency regarding the company ’ s supply of the majority of active pharmaceutical ingredients to all manufacturers across the board.
Knowing this in advance, we could have responded much faster, ” Dr. Steven Schundlemeyer, director of the PRIME Institute of the University of Minnesota School of Pharmacy, which focuses on economic and management issues, told the committee that as with defense contractors in the United States, New Zealand requires manufacturers to disclose their suppliers, and that information is required.
Easily accessible in the database.
Related Topics

All drug classes are vulnerable to shortages, with some of the most worrisome shortages including sterile injectable generic drugs, cancer chemotherapy drugs, and emergency drugs.

The economic implications of drug shortages on healthcare systems include the costs of workforce diversion, extended hospital stays, and other resource reallocations.

Manufacturing and quality problems, such as supply chain gaps and downtime, are often the root cause of drug shortages, rather than just high demand.

The FDA has identified manufacturing and quality problems, supply chain gaps, and downtime as contributing factors to drug shortages.

The shortage of generic chemical drugs can be caused by the closure of a single factory that manufactures the active ingredient, highlighting the need for greater transparency and diversification in the pharmaceutical supply chain.

Technology, specifically artificial intelligence, can be used to predict the structure of proteins, which may speed the discovery of new drugs.

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Data on drug availability, such as that provided by the Food and Drug Administration, can help track and respond to drug shortages.

Title:

Content: The lack of medicine continues to burn!
The Ministry of Health and Welfare has proposed a short, medium and long-term strategy to deal with the current 5 coping mechanisms.
Journalist Yen Zhenzhen / Taipei Report
According to the Ministry of Health and Welfare, the shortage of drugs is not a single factor, but includes supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits and drug prices. In addition to dealing with the relatively high clinical demand items, it is properly allocated to all levels of medical institutions and pharmacies to fully meet the needs of clinical end-use drugs.
This is an advertisement, please continue reading.
In the face of the shortage of drugs, Wang said, the existing health insurance uses five major coping mechanisms, including 1, a single processing window, a dedicated person to help deal with the problem of drug purchase, and contact the Food and Drug Administration to put relevant information on the website of the NHI. (4) Drug price adjustment mechanism that does not meet the cost can be re-checked according to the way of raising the price of special drugs; (5) Alternative drugs can still declare the cost, if they are not irreplaceable, they can be replaced at the same price or lower than the original prescription drug price.
In addition, Wang pointed out that in the face of the international epidemic, the Russian-Ukrainian war, and labor shortage, drug shortage is a problem facing all countries. In order to strengthen the stable supply mechanism of drugs in China, the Ministry of Health and Welfare continues to actively respond to the short-term strategy to solve the problem of drug shortage. The Food and Drug Administration (FDA) and the pharmaceutical industry have made every effort to actively arrange production lines, strive for early import, increase production / import quantity, and properly distribute to all levels of medical institutions and pharmacies to fully meet the demand for clinical end use drugs.
In addition, to properly handle the issue of drug price adjustment, the Central Health Insurance Administration of the Ministry of Health and Welfare intends to implement the "Universal Health Insurance Cost Distribution Target System (DET)" in April this year, which will adjust the number of drug prices and adjust the quota in a suitable manner, taking into account factors such as the epidemic, the Russian-Ukrainian war and inflation.
In terms of medium-term strategy, Wang said that he will establish a permanent drug shortage treatment center and optimize drug supply information transmission.
In order to speed up the handling of drug shortage incidents, we will adopt dedicated personnel and cross-departmental cooperation to develop drug shortage prevention policies to prevent drug shortage in advance, strengthen cross-departmental data integration and proactive monitoring to detect drug shortage incidents at an early stage, and intervene early through cross-departmental cooperation to stabilize drug supply.
At the same time, the Food and Drug Administration (FDA) continues to disseminate drug supply and alternative drug information through various channels. In addition to posting on the “Drug Supply Information Platform ”, the FDA will notify medical institutions and pharmacies through VPN, and weekly letters to relevant medical associations and public associations to inform members. Management system.
In the long-term strategy section, it includes reviewing the current health insurance drug pricing policy and encouraging the production of domestically manufactured generic drugs.
Wang Bi-sheng pointed out that in the review of the current health insurance drug price policy, including the development of the price protection of indicative drugs, drug price review for the lack of drugs; start the review of drug expenditure target (DET), plan the establishment of a risk control mechanism, plan the national unified procurement trial plan; comprehensively review the health insurance drug price policy, give an appropriate price protection mechanism for necessary drugs, and also target the patent period. To encourage the production of domestic manufacturers to ensure that when there is a shortage of original pharmaceutical products, there are domestic famous drugs to respond.
Wang also stressed that the Food and Drug Administration has set up a "Drug Supply Information Platform" (https: / / dsms.fda.gov.tw /), reporting hotline (02) 27878249. If medical institutions and pharmacies have any shortage of drugs, they can go to the platform for enquiry or notification, and the department will deal with it immediately.
This is an advertisement, please continue reading.

Title:

Content: Cai Ing-wen: Thanks for 8 years of support, the epidemic and the government work together
Journalist Chen Wei-uei / reporting from Taipei
President Tsai Ing-wen attended the Spring Wine Dinner of the National Federation of Pharmacists of the Republic of China (ROC) on the evening of today (25), saying that the Ministry of Health and Welfare, the Food and Drug Administration and the National Health Insurance Administration have actively responded to the shortage of drugs.
In the future, Taiwan will enter an ultra-aging society, medical treatment combined with technology will become the norm, and the government will continue to improve and amend laws and regulations in a timely manner, looking forward to improving medical services.
This is an advertisement, please continue reading.
Tsai Ing-wen said in her speech that this year, the All Federation of Pharmacists Association will soon reach its 44th anniversary, and the past presidents and supervisors are committed to fighting for the rights of pharmacists, and also let the Federation become a bridge for communication between the government and the industry, so that the government can hear the voice of the pharmaceutical industry and be closer to public opinion in policy.
She would like to thank President Huang Jinshun for his leadership over the past few years, as well as all the good friends of pharmacists to protect the health of the people of the country.
At the same time, she also wants to spend her old age, and wish everyone a happy and safe New Year.
In the past few years, in the face of the challenges of the epidemic, all pharmacists have worked hard to stand on the front line, not only to mobilize drugs, but also to help the government release masks and rapid screening tests.
Tsai Ing-wen said that in addition to going deep into the community and the Changshu Center, the Association also shares Taiwan's experience in epidemic prevention and public health with pharmaceutical organizations around the world, so that the world can see Taiwan, give full play to the spirit of "Taiwan Can Help," and contribute its own efforts to the world.
Tsai Ing-wen pointed out that the government knows that the world is facing a shortage of drugs in recent years, and has asked the Ministry of Health and Welfare, the Food and Drug Administration, and the National Health Insurance Administration to actively respond to the problem.
At present, the "Drug Market Monitoring System" has been launched. This system will strengthen the monitoring of the supply of pharmaceutical products in the middle market, so that the front-line pharmacists can query the inventory of pharmaceutical products more quickly and ensure the rights and interests of the public.
Tsai Ing-wen stressed that Taiwan's society is entering an ultra-old age, and in the case of fewer children, the medical needs for home care will continue to increase.
In the future, medical combined technology will become the norm, such as telemedicine services and smart medical services that have been opened up.
The government will also continue to improve and amend regulations in a timely manner to ensure information security and patient privacy, and improve medical services.
Finally, Tsai thanked everyone for their support during her eight-year term in office, which allowed Taiwan to “pass through and overcome the barriers. ”
During the 100-year pandemic, I would like to thank my friends and the government for their hard work, so that Taiwan's epidemic prevention performance has been recognized by the world, and so that the public can better understand the role of pharmacists in the national epidemic prevention and medical system.
This is an advertisement, please continue reading.

Title:

Content: - A plus A.
@ Okaz _ online
The Health Committee of the Shura Council held a meeting - via video call - chaired by the member of the Council and Vice Chairman of the Committee Dr. Hassan bin Salem Al Masloom to discuss the topics on the agenda of the Committee, and referred to it by the Council to discuss them and submit its reports containing its opinion and recommendations on them in the coming period.
During the meeting, the Committee examined the highlights of the annual report of the Red Crescent Authority for the fiscal year 1442 / 1443, and the information and figures included in the report showing the performance of the Authority during the reporting year.
During the meeting, the committee pointed out the importance of the Authority's development of the devices and equipment used to suit the size of the large services it provides, the most important of which is the provision and modernization of ambulances in sufficient numbers with international specifications technically and technically to provide the best ambulance services and save the lives of the injured.
During the meeting, the committee considered the importance of benefiting from the programs and large databases, and the potential of artificial intelligence to help predict the increase or decrease of the demand for ambulatory services, and guide the supervisors of ambulatory services to transfer or focus the crews to fill the need for excess requests, and raise the efficiency and better use of resources.
During the meeting, the Committee examined the annual report of the Saudi Food and Drug Authority for the fiscal year 1442 / 1443, and the challenges it faces in raising the efficiency of services provided and creating innovative technical solutions to enhance the quality of services and stimulate digital infrastructure.
The committee discussed the importance of the Authority ’ s website containing indicators and an interactive panel with information on the shortage of medicines, raw materials and devices, which is updated regularly, which helps health facilities and consumers to develop appropriate measures and plans to contribute to the ease of research and access to information for the beneficiary.
On the other hand, the Water, Agriculture and Environment Committee of the Shura Council held a meeting - via video call - chaired by the Council member and Chairman of the Committee, Dr. Khalid bin Mahmoud Zubair, to discuss a number of topics referred to the Committee for consideration and submit its reports containing its opinion to the Council in the coming period.
Among the topics discussed by the Committee was the annual report of the National Center for Research and Development of Sustainable Agriculture (Estidama) for the fiscal year 1442 / 1443.

The use of technology, such as the 'Drug Supply Information Platform', can help predict, prevent, and respond to drug shortages by providing real-time information on drug availability and alternative drugs.

Data analytics can be used to identify patterns and trends in drug shortages, allowing for proactive monitoring and early intervention.

Title:

Content: Express Computer
Home  »  Guest Blogs  »  The next frontier: Investing opportunities in India’s burgeoning healthtech sector

The next frontier: Investing opportunities in India’s burgeoning healthtech sector

0 17

By Karna D Shinde, Strategic Investor and Advisor

As the world continues to navigate through the complexities of healthcare, India’s burgeoning healthtech sector emerges as a beacon of innovation and opportunity. Led by visionary entrepreneurs, technological advancements, and fueled by the pandemic, the sector saw a boost in investments.

However, the primary drivers of growth in India’s healthtech sector is the increasing adoption of digital health solutions. With the widespread penetration of smartphones and internet connectivity, telemedicine platforms have witnessed a surge in demand, especially in remote and underserved areas. These platforms enable patients to consult with healthcare providers remotely, thereby reducing barriers to access and improving healthcare outcomes. Additionally, digital health records and data analytics tools are streamlining patient care and enhancing clinical decision-making processes.

As governments and healthcare organisations prioritise digitisation initiatives, there is a growing need for innovative healthtech solutions that can address evolving challenges effectively. As per experts, India’s digital healthcare market is expected to generate $37 billion in revenue by 2030. Investors keen on capitalising on this trend can explore opportunities in telemedicine platforms, digital health infrastructure and remote patient monitoring systems.

In 2023, the healthcare sector witnessed a significant focus on investments, particularly in hospitals and health tech start-ups, according to EY. Hospitals emerged as the primary beneficiary, capturing 62% of all private equity and venture capital investments within healthcare, followed closely by health tech, which secured a 23% share. Notably, India’s healthtech sector experienced a surge in attention, particularly in the realm of healthcare AI and machine learning applications. These technologies are poised to revolutionise various aspects of healthcare, including diagnostics, drug discovery, and personalised medicine. AI-powered platforms have the potential to analyze extensive medical datasets, unveiling crucial patterns, predicting disease outcomes, and optimising treatment strategies. By harnessing machine learning algorithms, healthcare providers can offer more precise diagnoses, tailor treatment plans to individual patients’ needs, and enhance overall efficiency in healthcare delivery.

Furthermore, the integration of wearable devices and IoT (Internet of Things) sensors is transforming preventive healthcare and wellness management. These devices enable continuous monitoring of vital signs, physical activity levels, and other health parameters, empowering individuals to take proactive measures to maintain their well-being. Investors interested in this space can explore opportunities in wearable technology startups, IoT-enabled healthcare devices, and data analytics platforms that harness real-time health data for actionable insights.

In addition to technological innovation, regulatory reforms and government initiatives are driving growth and investment opportunities in India’s healthtech sector. The Indian government’s push for universal healthcare coverage and the implementation of digital health frameworks are creating a conducive environment for industry growth. Moreover, collaborations between public and private stakeholders are fostering innovation and entrepreneurship in healthcare delivery models.

For investors looking to capitalize on India’s healthtech boom, it is essential to conduct thorough due diligence and identify promising startups with scalable business models and strong leadership teams. By investing in early-stage ventures with disruptive technologies and a clear value proposition, investors can position themselves for significant returns in the long term.

India’s healthtech sector presents compelling investment opportunities driven by technological innovation, changing consumer preferences, and supportive regulatory frameworks. As the demand for accessible, affordable, and quality healthcare continues to grow, investors have a unique chance to participate in the transformation of India’s healthcare landscape while generating substantial returns on their investments. With the right strategic approach and a focus on innovation and impact, investing in India’s healthtech sector could prove to be the next frontier for savvy investors.

Get real time updates directly on you device, subscribe now.

LIVE Webinar

Digitize your HR practice with extensions to success factors

Join us for a virtual meeting on how organizations can use these extensions to not just provide a better experience to its’ employees, but also to significantly improve the efficiency of the HR processes
REGISTER NOW
India's Leading e-Governance Summit is here!!! Attend and Know more.
Register Now!
Attend Webinar & Enhance Your Organisation's Digital Experience.
Register Now
Enable A Truly Seamless & Secure Workplace.
Register Now
Attend Inida's Largest BFSI Technology Conclave!
Register Now
Know how to protect your company in digital era.
Register Now
Protect Your Critical Assets From Well-Organized Hackers
Register Now
Find Solutions to Maintain Productivity
Register Now
Live Webinar : Improve customer experience with Voice Bots
Register Now
Live Event: Technology Day- Kerala, E- Governance Champions Awards
Register Now
Virtual Conference : Learn to Automate complex Business Processes
Register Now

Digital health solutions, such as the 'Universal Health Insurance Cost Distribution Target System', can help adjust drug prices and quotas, taking into account various factors that affect drug supply and demand.

The Ministry of Health and Welfare has proposed a short, medium, and long-term strategy to deal with the current drug shortage.

The shortage of drugs is caused by multiple factors, including supply problems, manufacturing problems, clinical demand factors, uneven distribution of drugs, drug use habits, and drug prices.

The COVID-19 pandemic has accelerated the adoption of new technology, with companies digitizing activities 20-25 times faster than previously observed, according to a McKinsey study.

Title:

Content: BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

Analytics And Insight: Digging Into Data

Kathleen Brunner is the founder, current CEO and President of Acumen Analytics.

While there is cautious optimism, the pandemic continues to impose pressure points and challenges requiring us to change the way we do things. This period in time calls for us to significantly broaden our thinking.

The need for collaboration in organizations has never been more apparent, and the challenges of collaboration never greater. Eliminating departmental working silos is only the beginning. The entire ecosystem needs to be strung together in a secure yet frictionless communication framework, allowing a connected data flow and integrated view of data to achieve the ultimate strategic plan, speed to market and overall success. This need was greatly amplified throughout the pandemic and specifically across life sciences industries. One spotlighted area is pharmaceutical supply chain practices, business continuity and drug/supply shortage prevention.

But many leaders are wondering: How can my organization be future-ready?

The biotech and pharma spaces are often lagging in adopting new technology for a variety of reasons, often due to regulatory and validation requirements. While not specifically focused on life sciences, a recent McKinsey study indicates one silver lining of the Covid-19 crisis is that companies appear to be digitizing many activities 20-25 times faster than previously observed.

Data

Data is being generated rapidly all around us. But, proper use, interpretation and understanding of this data is required for efficiency and successful outcomes. Industry 4.0 deepens the need for companies to ask the right questions regarding their data. In the biopharma world, technical changes are a crucial component of prosperity. Edge computing and smart manufacturing allow for more equipment to be digitally enhanced and cloud-enabled. Temperature monitoring of a shipment from factory to pharmacy is a great example of this.

Additional investments in technology are key to the education and implementation of systems capable of handling high data volumes through experiments that produce large data sets (i.e., metabolomics). After all, data can be meaningless if not interpreted correctly. Success can be achieved by following the lead of other industries that have shifted away from a "this is how we have always done it" mindset.

Digital Transformation

But why all this talk about digital transformation now? Executives are being pressed daily that they need to "go digital." It's transform or be left behind.

This is not new; ERP systems began this process in the 1990s. But what does digital transformation really mean? It is not just about technology; it's about rethinking the current, often longstanding processes with a new approach where technology is not the driver but rather the enabler — new ways through evolution and innovation to change customer, vendor, employee experience. It is a mindset of continuous improvement, a shift to include more data, faster, from more devices (e.g., wearables, sensors, watches, machines, etc.) to reduce risk and increase insights by transforming data into intelligent decision-making. This includes artificial intelligence (AI), machine learning (ML), robotic process automation (RPA), blockchain and the Industrial Internet of Things (IIoT).

Bottom Line

The key to success will be to understand where and what technology is relevant and what to invest in. Lack of clarity could prove to be expensive, wasting effort and resources and potentially impeding organizational success.

Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

Follow me on Twitter or LinkedInCheck out my website

Data analytics and digital health solutions can play a crucial role in predicting, preventing, and responding to drug shortages by providing real-time monitoring and insights.

The Taiwanese government has launched a 'Drug Market Monitoring System' to strengthen the monitoring of pharmaceutical product supply in the middle market.

The 'Drug Market Monitoring System' allows front-line pharmacists to query the inventory of pharmaceutical products more quickly, ensuring the rights and interests of the public.

India's healthtech sector is growing due to the increasing adoption of digital health solutions.

Digital health solutions, such as telemedicine platforms, are improving healthcare outcomes by reducing barriers to access and enabling remote consultations.

The Health Committee of the Shura Council discussed the importance of benefiting from programs, large databases, and artificial intelligence to predict demand for ambulatory services.

Artificial intelligence can help guide supervisors of ambulatory services to transfer or focus crews to fill excess requests and raise efficiency.

Drug shortages are estimated to cost facilities at least $359 million per year.

Title:

Content: Skip to content

Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology …

Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology …

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication … It is estimated that drug shortages are costing facilities at least $359 million per year in … More than 50,000 institutional and retail pharmacies across North America …
See all stories on this topic

Nearly 75 per cent of Ontario doctors experienced burnout during pandemic, survey says …

Nearly 75 per cent of Ontario doctors experienced burnout during pandemic, survey says … as COVID-19 was first hitting North America – that saw 66 per cent of respondents report some level of … Dr. Adam Kassam, president of the OMA, said physician burnout has always been a problem, but it’s been …
See all stories on this topic

Health researchers report funder pressure to suppress results – Nature

These trials, published between 2007 and 2017, were cited in Cochrane reviews, which are considered the ‘gold-standard’ of evidence used to inform …
See all stories on this topic

Survey: nearly 75 per cent of Ontario doctors experienced burnout during pandemic – Toronto Star

Dr. Carolyn Snider felt a gamut of emotions while working in one of the busiest emergency rooms in Canada during the last 18 months of the …
See all stories on this topic

Asia-Pacific Over the Counter (OTC) Drugs Market 2021 Segmented by Product, Distribution …

North America currently holds the largest share in the market, due to the increasing expenditure in healthcare. Inclination of Pharmaceutical Companies …
See all stories on this topic

Published inSubstance Abuse

More than 50,000 institutional and retail pharmacies across North America are affected by drug shortages.

Technology and automation can play a role in predicting, preventing, and responding to drug shortages, as evidenced by Omnicell's advancements in automation, intelligence, and technology.

The use of data analytics and digital health solutions can potentially help mitigate the effects of drug shortages.

The main challenges in implementing technology, data analytics, and digital health solutions to address drug shortages include unsupportive regulatory systems and limited human capacity.

Title:

Content: Senior Advisor at Sinopharm CNBG and G42, Dr. Nawal Al Kaabi will share her experience and expertise at the latest edition of the region ’ s leading technology event
Dubai, United Arab Emirates: Dr. Nawal Al Kaabi, a biotechnology researcher, will pay a special visit to GITEX 2022, where she will share her personal experience and expertise in community protection and drug and treatment safety, through her long career and prominent role in Hyatt Biotech, a UAE-China joint venture, where she is Senior Advisor.
Hyatt Biotech, a joint venture between Abu Dhabi-based artificial intelligence and cloud computing company G42 and Chinese pharmaceutical company CNBG Sinopharm, is responsible for manufacturing and distributing the Covid-19 inactivated BBiB-CorV vaccine, which has enabled the UAE to become self-sufficient in its vaccine supply.
The company is also in advanced negotiations to supply the vaccine to other neighboring countries and ensure fair and equal access to the vaccine.
Dr. Al Kaabi will be giving a talk at the G42 ’ s private stand today, as part of her role as Senior Advisor at Hayat Biotech, exploring the biotechnology that is shaping the present and future of healthcare.
The rapidly evolving scientific sectors are upgrading the medical sector in general, providing tools to reduce and control infectious diseases, enhancing knowledge about specific disorders and increasing efficiency in manufacturing processes.
Nasser Al Yamahi, Executive Vice President, Hayat Biotech, emphasized the importance of this approach when commenting on the event: “Together with our team of healthcare professionals, we share our desire and vision and work together to achieve leadership in the provision of new science-based, technology-based and human-centric solutions.
We look forward to driving real and meaningful positive change, providing the world with access to preventative medicine, and empowering individuals to make informed decisions about their future health and safety. ”
Following the lecture, Dr. Al Kaabi will take part in a digital video conversation, during which she will discuss the importance and role of local R & D and manufacturing in establishing and promoting a sustainable healthcare system.
Dr Al Kaabi said: “Local ecosystems for R & D are providing a driving force that will reshape and restructure the sector. ”
“Local production of medicines plays a vital role in maintaining the resilience of national healthcare systems, particularly in terms of facilitating access to needed medicines and reducing the urgency of importing medicines and international supply chains. ”
The digital conversation will also highlight the prospects of the pharmaceutical sector as a research-intensive industry, the systematic lack of governance and support for R & D activities in this sector, along with a host of other related issues and topics.
“Unsupportive regulatory systems and limited human capacity are only key factors in a set of major barriers that negatively impact the diversification of the locally produced drug portfolio, ” said Dr. Al Kaabi.
The event will be attended by Hongbin Chong, CEO of Hyatt Biotech, who will conduct a number of media interviews to highlight and discuss the journey and efforts of biotech professionals to establish an efficient ecosystem around the world, in the UAE and in the region, including the state-of-the-art KIZAD center.
G42 ’ s own stand will be in Hall 6A, Stand 20 at GITEX, and the digital conversation will be broadcast via G42 ’ s official platforms.
# Company Data
- Done.

Local production of medicines plays a vital role in maintaining the resilience of national healthcare systems by facilitating access to needed medicines and reducing reliance on international supply chains.

Digital health integration and AI are considered vital solutions to enhance patient care and address biases in the healthcare system.

Title:

Content: Global Healthcare Facing Severe Workforce Shortage by 2035

TL;DR Breakdown

  • Global healthcare is in a crisis, with a projected shortage of 18 million workers by 2035.
  • Digital health integration and AI are vital solutions to enhance patient care and address biases.
  • Connectivity and shared learning are key to bridging healthcare gaps and improving the system.

Healthcare systems worldwide face complex challenges, including an aging population, disparities in healthcare access, and a scarcity of healthcare professionals. Alarming projections from the World Health Organization (WHO) estimate a severe shortfall of 18 million healthcare workers by 2035, further exacerbated by the recent pandemic.

During a recent keynote session titled “Health that Connect, Tech that Cares,” Hal Wolf, HIMSS President and CEO, advocated for a proactive approach. He suggested that integrating digital health seamlessly into healthcare facilities is a promising solution. This involves deploying advanced technologies and providing comprehensive training to the workforce.

The crucial role of AI in personalized care

Central to this strategy is the adoption of artificial intelligence (AI) to deliver personalized care more efficiently. Hospitals have now harnessed predictive modeling capabilities, enabling care teams to prioritize cases and redirect time from manual patient testing to direct patient care. Wolf emphasizes recognizing AI as a valuable tool in the healthcare toolkit.

Wolf further emphasizes that a clear vision must guide any development of AI applications. It is crucial to identify and rectify biases that might inadvertently affect AI applications. Additionally, the accuracy and integrity of healthcare data, particularly in electronic medical records (EMRs) and data structures, are paramount for informed decision-making.

Robust connectivity is another critical factor to consider. This entails ensuring that care teams can access essential tools and applications anywhere. Notably, initiatives like Indonesia’s plan to introduce satellite connectivity for rural community health centers are helping bridge healthcare disparities in underserved communities.

Hal Wolf concludes by urging participants to openly share their experiences and insights gained during their digital transformation journeys. This collaborative approach, encompassing successes and challenges, is essential for continuously improving healthcare systems.

An impending global healthcare crisis

The global healthcare sector is on the brink of a severe crisis. Challenges, including a rapidly aging population, persistent healthcare disparities, and a widening workforce gap, have created a daunting scenario. The WHO’s prediction of an 18 million health worker shortage by 2035 is a stark warning for all stakeholders.

Digital health integration

To mitigate this impending crisis, experts recommend a multifaceted approach. At the forefront is the seamless integration of digital health into healthcare facilities. This transformation involves incorporating technology as an integral part of healthcare infrastructure and investing in workforce training to harness its full potential.

The role of artificial intelligence (AI) in healthcare is paramount. With predictive modeling capabilities, hospitals can streamline patient care by prioritizing cases efficiently. However, it is essential to view AI as a valuable tool with limitations, as Hal Wolf emphasized.

Developing AI applications requires a clear vision and a commitment to addressing biases that may inadvertently affect algorithms. Furthermore, maintaining and improving the integrity of electronic medical records (EMRs) and data structures is crucial to ensure reliable decision-making.

Efforts to bridge healthcare gaps extend to ensuring robust connectivity. Initiatives like Indonesia’s plan to introduce satellite connectivity for rural community health centers exemplify the commitment to ensuring healthcare resources are accessible, even in underserved areas.

Learning from experience

Sharing lessons learned becomes paramount as healthcare organizations embark on digital transformation journeys. Hal Wolf’s call to openly discuss both successes and challenges fosters an environment of collective growth.

The global healthcare sector faces an imminent workforce crisis that necessitates immediate action. The integration of digital health, AI-driven personalized care, bias mitigation, data integrity assurance, and robust connectivity are crucial steps to address these challenges. Collaboration, open dialogue, and shared experiences will be pivotal as healthcare systems prepare for the impending workforce shortfall worldwide.

Disclaimer. The information provided is not trading advice. Cryptopolitan.com holds no liability for any investments made based on the information provided on this page. We strongly recommend independent research and/or consultation with a qualified professional before making any investment decisions.

The adoption of artificial intelligence (AI) can deliver personalized care more efficiently, and hospitals have started using predictive modeling capabilities to prioritize cases.

The accuracy and integrity of healthcare data, particularly in electronic medical records (EMRs) and data structures, are essential for informed decision-making.

The Digital Health Market is expected to reach $586.59 billion by 2030, growing at a CAGR of 16.80% during the forecast period (2023-2030).

Title:

Content:
Global Digital Health Market On Rise: Comprehensive Analysis Projected To Hit $586.59 Billion By 2030

(MENAFN- EIN Presswire)

Vantaga Market Research

Digital Health Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030

Vantage Market Research Report for Semiconductor Market- A Closer Look at the Future of Digital Health” - Vantage Market ResearchWASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, February 5, 2024 /EINPresswire / -- The Global Digital Health Market Size was valued at USD 169.36 Billion in 2022, and it is expected to reach USD 586.59 Billion by 2030, growing at a CAGR of 16.80% during the forecast period (2023-2030).

Digital Health is revolutionizing the healthcare sector, integrating technology to enhance patient care, streamline processes, and improve overall health outcomes. This burgeoning field encompasses a broad spectrum, including telehealth , wearable devices, health information technology, and more. The Digital Health Market is experiencing unprecedented growth, driven by technological advancements and a growing emphasis on preventive healthcare.

Download a Sample Report Here @

Digital Health is a transformative approach to healthcare, leveraging technology to empower patients, enhance communication between healthcare providers and patients, and optimize health outcomes. The market is propelled by the increasing adoption of mobile health apps, remote patient monitoring, and the integration of artificial intelligence in healthcare solutions. The key driving factors include the rising prevalence of chronic diseases, the need for efficient healthcare delivery, and the demand for personalized and patient-centric care.

This report delves into the multifaceted landscape of the Digital Health Market, exploring its dynamics, top trends, challenges, opportunities, key report findings, and a focused regional analysis on the burgeoning North America region.

Market Dynamics

The Digital Health Market is characterized by dynamic factors that shape its trajectory. Rapid advancements in technology, increasing healthcare expenditure, and a shift towards value-based care are driving market growth. The integration of electronic health records (EHRs), telemedicine services, and the proliferation of wearable devices contribute to the market's dynamism. Additionally, regulatory support and initiatives promoting interoperability play a pivotal role in fostering innovation and adoption.

Top Companies in Global Digital Health Market

. Allscripts Healthcare Solutions Inc. (US)
. Cisco Systems (US)
. Koninklijke Philips N.V. (Netherlands)
. McKesson Corporation (US)
. and Cerner Corporation (US)

To Get a Customised List of Companies Please Click Here @

Top Trends

✧ Telehealth Revolution: The accelerated adoption of telehealth services for remote consultations and virtual care.
✧ Wearable Technology: The surge in popularity of wearable devices for real-time health monitoring and fitness tracking.
✧ Artificial Intelligence in Healthcare: The integration of AI for predictive analytics, diagnostics, and personalized treatment plans.
✧ Blockchain in Healthcare: Growing utilization of blockchain for secure data sharing, enhancing interoperability and data integrity.

Global Digital Health Market Segmentation

By Technology

. Telehealthcare
. mHealth
. Healthacare Analytics
. Digital Health Systems

By Component

. Hardware
. Software
. Services

Buy Now this Premium Research Report at a Special Price Against the List Price With [Express Delivery] @

Top Report Findings

✧ Increasing market consolidation among key players Allscripts Healthcare Solutions Inc., Cisco Systems, Koninklijke Philips N.V., McKesson Corporation.
✧ Growing emphasis on cyber security in Digital Health solutions.
✧ Rise of patient-centric care models.
✧ Integration of Virtual Reality (VR) and Augmented Reality (AR) in healthcare applications.

Get a Access To Digital Health Industry Real-Time Data @

Challenges

The Digital Health landscape faces challenges, including interoperability issues, data security concerns, and the need for standardized regulations. Achieving seamless integration across diverse platforms, ensuring patient privacy, and addressing resistance to technology adoption are pivotal challenges.

Opportunities

As the Digital Health Market evolves, numerous opportunities emerge. The market offers a fertile ground for innovative startups, collaborations, and partnerships. Leveraging data analytics for population health management, enhancing patient engagement, and expanding telehealth services present promising avenues for growth.

Key Questions Answered Digital Health Market in the Report:

✦ How is the Digital Health Market expected to evolve in the next five years?
✦ What role does artificial intelligence play in shaping the future of Digital Health?
✦ How are regulatory frameworks influencing the adoption of Digital Health solutions?
✦ What are the key challenges hindering widespread Digital Health implementation?
✦ How are healthcare providers navigating the transition towards value-based care?
✦ What innovations are driving the transformation of patient-centric care models?
✦ How can interoperability challenges be addressed to ensure seamless Digital Health integration?
✦ What are the emerging trends in wearable technology and their impact on healthcare?

Read Full Research Report with TOC @

Regional Analysis

North America dominates the Digital Health Market, driven by a robust healthcare infrastructure, technological advancements, and supportive government initiatives. The region showcases a high adoption rate of Digital Health solutions, with a focus on improving healthcare accessibility and outcomes. The presence of major industry players, coupled with increasing investments in research and development, solidifies North America's position as a frontrunner in the Digital Health revolution.

Check Out More Research Reports

✦ Healthcare IT Integration Market Forecast Report:
✦ Home Healthcare Market Forecast Report:
✦ Cochlear Implants Market Forecast Report:
✦ Cancer Diagnostics Market Forecast Report:
✦ Recycled Plastic Market Forecast Report:
✦ Human Identification Market:
✦ mHealth Market:
✦ Remote Healthcare Market:
✦ Healthcare Additive Manufacturing Market:

About Us

Since VMR establishment, we have been supporting the global expansion of companies through the sale of overseas market research reports. With offices in 6 countries around the world, we provide a one-stop shop with approximately 100,000 research materials published by over 250 overseas affiliated research companies. Aiming to be a global leading company in market information sales, we deliver truly valuable information to our customers in order to contribute to the development of companies and society.

Eric Kunz
Vantage Market Research
+ + +1 202-380-9727
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
YouTube

MENAFN05022024003118003196ID1107809547

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

The main challenges facing the Digital Health landscape include interoperability issues, data security concerns, and the need for standardized regulations.

Achieving seamless integration across diverse platforms, ensuring patient privacy, and addressing resistance to technology adoption are pivotal challenges in the Digital Health Market.

Digital health tools can address issues of lack of healthcare access, lack of coordinated care, and interoperability problems in a streamlined and personalized way.

Title:

Content: BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

Hacking Healthcare Innovation

Dr. Waqaas Al-Siddiq DBA, founder of Biotricity, is a serial entrepreneur, a former investment advisor, and a technology expert.

Digital health can be simply defined as both healthcare innovation and its future. Digital health tools provide a means for patient-centered care that was previously available only to a select few. As a population, we are more aware of what is considered healthy, but for many of us, our health continues to decline. Historically, this issue has largely been due to a lack of healthcare access, a lack of coordinated care and/or issues with interoperability. Digital health can address each of these problems in a streamlined way that is personalized to each patient's condition. This can result in improved outcomes.

Digital health has successfully integrated technology into healthcare by facilitating on-demand, whole-person monitoring. Whole-person care focuses on and tracks individuals from labs to diagnostics to disease management and intervention, when necessary. Yet, digital healthcare penetration continues to face many challenges. Those challenges threaten innovation by slowing our pace.

While digital health is trending, and a focus of innovators worldwide, many current healthcare solutions remain outdated. As an entrepreneur in the healthcare space, I've found that innovation is often hindered by regulatory hurdles. Products are required to meet safety, quality, data security, functionality, data protection and interoperability guidelines. Once products meet those requirements, they become eligible for regulatory review and may qualify for insurance reimbursements. The review timeline and requirements vary depending on the type of product. Some, for example, require long studies and long-term clinical data. All hurdles aside, digital tools are well-suited to improve morbidity, mortality, costs and quality of life.

In contrast, we have the simplest form of healthcare products with the fastest path to commercialization: healthcare apps. Acquiring clinical data for them is often hard because data is gathered from mobile apps and widely used by the public. That data is naturally skewed since individuals accessing those apps are on average younger and healthier. This data is self-regulated by mobile users and, in my experience, is often abandoned before you gain any long-term data or substantial insights. There is usually no way to prove data reliability, validity or the effectiveness of those tools. To achieve accountability and ensure data reliability, physicians would need to monitor. The problem is, why would physicians be motivated to review self-generated data for free?

Depending on what healthcare problem you’re tackling, it can become more complicated when you consider medical codes for provider reimbursement. It can be difficult and time-consuming for new medical codes to be developed for innovative technologies and treatments. This can further stretch commercialization timelines. Such hurdles can add costs and make healthcare innovation expensive and market penetration more difficult.

Depending on the area of focus, costs can be higher still. For example, it's expensive and time-consuming to manufacture new drugs. Drug developers need to show clinical evidence that their drugs are safe and effective before approval. However, it may be difficult to observe side effects with so many limitations in duration and scope. Often, adverse effects only surface after the drug has been widely used. This is where digital health can provide valuable insights into improving the quality of care and lowering its costs.

So, how can we, as innovators in the healthcare space, overcome these hurdles?

Consider Where You Choose To Innovate

We know that chronic conditions account for 75% of healthcare spending, so innovation in chronic diseases is paramount. How can we innovate without slowing down? First, innovate to support the institutions that deliver care or develop technologies that eventually service the patient directly. We already know what’s accessible to patients: electronic patient portals, telemedicine services, wearable devices and online chats. We know what they should achieve as an ecosystem, but are patients really empowered? Is the quality of care really improved? We can innovate to correct deficiencies and misconceptions to improve the overall patient experience.

Consider How You Choose To Innovate

Focus on connectivity. Get the ball rolling with interconnected therapeutic and diagnostic products and services. That way, you can generate valid long-term data that you can use to improve precision medicine and leverage predictive analytics.

Align With An Existing Reimbursement Code

The former two give you the fastest path to commercialization if you can figure out reimbursement, a key issue in healthcare innovation. I've found that the best approach is to hire a reimbursement specialist and analyze reimbursement in the space in which you are trying to innovate—look for an established medical code that is directly related to your space. Based on that, you can innovate and shorten the whole process and develop a solution that fits within that code.

Digital Health: The Final Frontier

The benefits of digital health technologies for clinical care and research will be appreciated when you've resolved the aforementioned challenges. Digital health will interconnect patient data from telehealth, remote patient monitoring and remote diagnostics, creating more holistic patient views. This will ultimately drive the adoption of more evidence-based technologies.

We can innovate without getting bogged down. We must examine our current challenges and restrictions and proactively change the status quo. Data quality, safety, privacy, user-friendliness and reimbursement issues can all be mitigated. We need to work closely with our stakeholders and create early collaborations to iron out kinks and leverage existing reimbursement codes. This is how we ensure that digital health improves outcomes, reduces costs and improves the quality of care.

Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?

Follow me on Twitter or LinkedInCheck out my website

Digital health has successfully integrated technology into healthcare by facilitating on-demand, whole-person monitoring.

The biotech and pharma spaces are often lagging in adopting new technology due to regulatory and validation requirements.

Proper use, interpretation, and understanding of data are required for efficiency and successful outcomes in the biopharma world.

The growth of e-mental health care has been huge, with a 6,500% increase in doctors recommending apps to patients in 2021.

Title:

Content: Pixels Are Not People: Mental Health Apps Don’t Solve Everything

Technological solutions to fill the gap in mental health care are alluring. They can appear to be a cheap, scalable way to solve the knotty problem of mental distress, without requiring investment in people, communities and broader causes of mental ill-health such as racism, poverty or the way we design our cities.

Consequently, there has been huge growth in what’s now termed “e-mental health care” – mental health services and information delivered or enhanced through the internet and related technologies. In 2021, we saw a 6,500% increase in doctors recommending apps to patients.

This growth is a response to growing problems of unmet mental health needs, shortage of clinicians, and a lack of access to mental health care in Aotearoa New Zealand.

But the increasing investment in e-mental health apps can ignore the shortcomings of technology.

As both a practitioner and researcher promoting mental health in communities, I see policy makers and funders dazzled by shiny new apps, which can divert the government’s investment in traditional – but costly – mental health care.

Here’s why we need more conversation and rigorous evaluation of e-mental health.

Technology to help mental health

There are 33 mental health apps listed on Aotearoa’s Health Navigator site, and another new bilingual mindfulness app was launched recently.

App development has accelerated since the pandemic, with three funded through the NZ$500 million COVID-19 response health package in 2020.

Digital infrastructure and e-medicine is a key priority nationally: this year alone, the New Zealand government earmarked over $600 million to invest in data and digital infrastructure in the health system.

Supporters claim technology can counter isolation, anxiety, provide therapy and accelerate access and quality of care. And while there are some who benefit from e-mental health innovations, more research is needed to develop and test e-mental health interventions.

A key challenge is that individual technological solutions build on the underlying assumption that individuals are responsible for their own health outcomes, without addressing the structural, political and social causes of ill-health.

Dependent on access to technology

Convenience and affordability are described as the most obvious advantages of local and international apps like Aroha Chatbot, Mentemia and Happify.

Yet while mental health apps might be affordable for a middle class resident of Auckland, Ahmedabad or Apia, e-mental health solutions depend on people being able to afford technology platforms (like smart phones) and data plans to drive them.

Digital technologies risk increasing disparities and often exclude the people who most need mental health support – older people, people with low incomes, and those with severe mental health problems. These high-need groups have been identified as those least likely to use e-mental health care.

Even when e-health solutions are provided free to the user through government health funding and investment, the research and development costs for digital health are high. This means mental health funding supports graphic design and tech companies instead of those who provide person-to-person care, which we already know is central for good mental health.

Other challenges that have emerged for large-scale implementation of e-mental health options include complex regulatory issues such as ensuring apps meet quality standards, and how such apps can be used across national borders. Apps also may not keep pace with new evidence and advances in mental health as well as clinicians can. And while there is often strong initial uptake and use, ongoing use of apps is less common.

Do the apps actually work?

Beyond the issues of access, other key questions need to be asked: do mental health apps work, and who do they work for?

There are clearly benefits for some people to have access to some form of immediate assistance via their phone or computer. But most research evaluating e-mental health care only looks at whether apps are appealing and easy to use.

Fewer studies assess whether e-mental health interventions improve mental health status or strengthen mental health long term. When e-mental health interventions are evaluated rigorously, usage in a trial setting is often over-reported compared to usage in the real world.

However pixels are not people, and e-mental health care is not a substitute for the genuine human connection that is core to mental health recovery. Human connection was identified as key in the post-earthquake period for Ōtautahi Christchurch, and globally during the COVID-19 pandemic.

Apps are not relational and rarely support building social connections and peer friendships. My own research has shown that, most of all, people with mental distress need support to build relationships, be socially included, participate in their communities and have the opportunity to participate in and co-design mental health care.

Addressing mental health also requires moving past the individual to the collective. It requires action to address the social and political factors that contribute to a person’s mental health.

Serious and complex global problems such as obesity, gender inequality, poor housing, colonialism, racism and barriers to social connectedness are the biggest causes of poor mental health. Apps can help some people as an adjunct to psycho-social care, but they cannot replace it.

Kaaren Mathias, Senior Lecturer in public health, University of Canterbury

This article is republished from The Conversation under a Creative Commons license. Read the original article.

E-mental health solutions depend on people having access to technology platforms and data plans, which can exclude those who need mental health support the most, such as older people, people with low incomes, and those with severe mental health problems.

Complex regulatory issues, such as ensuring apps meet quality standards, are a challenge for large-scale implementation of e-mental health options.

The research and development costs for digital health are high, which can divert funding away from person-to-person care.

The Saudi Food and Drug Authority faces challenges in raising the efficiency of services provided and creating innovative technical solutions to enhance the quality of services and stimulate digital infrastructure.

The Authority's website contains indicators and an interactive panel with information on the shortage of medicines, raw materials, and devices, which is updated regularly.

The use of artificial intelligence has the potential to help predict the increase or decrease of demand for ambulatory services and guide supervisors to transfer or focus crews to fill excess requests.

The use of large databases and artificial intelligence can help raise the efficiency and better use of resources in ambulatory services.